Clinical Trial Update: Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update evaluating the addition of an aromatase inhibitor to ovarian stimulation therapy in IVF treatment has completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Snippet

Sponsor: Sven O. Skouby | Conditions: Infertility | Phase 2, Phase 3 | Status: COMPLETED